Cantel Medical Corp. provides infection prevention products and services in the healthcare market.
Segments
The company operates through four segments: Medical, Life Sciences, Dental and Dialysis. The company operates its four segments through wholly-owned subsidiaries in the United States and internationally.
Medical segment
This segment designs, develops, manufactures, sells and installs an offering of products and services, including a circle of infection prevention solutions. The company...
Cantel Medical Corp. provides infection prevention products and services in the healthcare market.
Segments
The company operates through four segments: Medical, Life Sciences, Dental and Dialysis. The company operates its four segments through wholly-owned subsidiaries in the United States and internationally.
Medical segment
This segment designs, develops, manufactures, sells and installs an offering of products and services, including a circle of infection prevention solutions. The company’s products include endoscope reprocessing and endoscopy procedure products. Its endoscope reprocessing products and services include a range of automated endoscope reprocessing systems; high-level disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products, including software; other consumables, accessories and supplies used to high-level disinfect rigid endoscopes, endoscopes and other instrumentation; and technical maintenance service on its products.
The company’s endoscopy procedure products are designed to eliminate the challenges associated with proper cleaning and high-level disinfection of various reusable components used in gastrointestinal (GI) endoscopy procedures. Its procedure products include CO2 and water irrigation pumps and disposable procedure kits; sterile irrigation tubing; and single-use valves.
The company’s endoscopy products, majority of which are proprietary medical devices subject to rigorous standards and regulations, contribute to the safe use of endoscopes in healthcare facilities worldwide and improve the quality of healthcare delivery by reducing the threat of nosocomial (hospital/healthcare facility acquired) infections. In addition, the company’s disposable procedure products provide patient safety and infection prevention through the replacement of reusable devices requiring disinfection with its single-use products. In particular, such products are intended to reduce the challenges associated with proper cleaning and high-level disinfection of various reusable components used in GI endoscopy procedures.
The company designs, develops and manufactures majority of its endoscopy products. This segment offers various preventative maintenance programs, repair services and user training programs to support the operation of reprocessing systems through their lifetime. The company’s field service personnel and international third-party distributors install, maintain, upgrade and repair equipment.
Sales, Marketing and Distribution: The company sells and services its line of endoscopy products through its direct field sales and clinical support service organizations in the United States, Canada, the United Kingdom, Italy, the Netherlands, Belgium, Germany, France, Singapore, Malaysia, Australia, Hong Kong and Dubai. Elsewhere in Europe, the Asia Pacific and Latin America, the company primarily sells through independent distribution partners. In China, the company sells both directly and through distributors, based on regional market demands.
Competition: On a product basis, the company’s principal competitors are Steris, Olympus, Boston Scientific, ASP (a division of Fortiv), Metrex, Ruhof, Ecolab, ERBE, Getinge, SteelCo and Wassenburg.
Life Sciences segment
This segment designs, develops, manufactures, sells and installs water purification systems for medical and other bacteria controlled applications. The company also provides filtration/separation and disinfectant technologies to the medical and life science markets through a worldwide distributor network. Its products and services include central dialysis water purification systems, portable dialysis water purification systems, bicarbonate mixing systems, hollow fiber filters and other filtration and separation products, liquid disinfectants and cold sterilization products, ‘dry fog’ products, room temperature sterilization equipment and services, microbiological testing services, and clean-room certification and decontamination services.
The company’s products are designed for dialysis and other specific healthcare applications, research laboratories, food and beverage, and commercial industrial customers. Its water systems provide biologically pure water specific to its customers’ needs and site conditions, ranging from low-volume, reverse osmosis and deionization systems, to high-volume, turnkey purification systems. The company provides service and maintenance for water purification systems through aive network of regional offices in the United States and, to a smaller degree, in Canada.
The company’s expertise includes designing systems capable of delivering water for hemodialysis that meets the water quality standards and good manufacturing standards of the Association for the Advancement of Medical Instrumentation and all grades of U.S. Pharmacopeia (USP) water (water meeting the U.S. Food and Drug Administration (FDA) enforced standards of the USP, including ‘USP Purified Water’, which is a FDA requirement for the labeling of ‘purified’ bottled water). The company also packages these same technologies and expertise in industrial designs to meet the commercial industrial market requirements.
The company also offers a line of proprietary and third party filters utilizing hollow fiber membrane technology to remove impurities from liquid streams for a range of applications. Such applications include the filtering of ultrapure water to remove endotoxins, bacteria and other contaminants in medical environments to provide protection for patients undergoing treatments that use ultrapure water. Its therapeutic filtration products include hemoconcentrators, hemofilters and specialty filters utilized for therapeutic medical applications.
The company’s liquid disinfectant and cold sterilant products are used in the dialysis, medical, pharmaceutical and other industries. These products include surface disinfectants, as well as chemistries used to disinfect ultrapure water systems as part of overall procedures to control the contamination of systems by microorganisms and spores. The company’s ‘Dry Fog’ equipment dispenses its cold sterilant products in a micro-mist form into rooms and certain structures with complex geometries in order to achieve validated surface disinfection.
The company’s REVOX Sterilization Systems and Services business provides a room-temperature vapor sterilization method for use by medical device, pharmaceutical and biomedical industries. This technology provides the capability to sterilize products at room temperature, while reducing overall processing times and inventory and capital requirements associated with other industrial sterilization methods.
Sales, Marketing and Distribution: The company sells its equipment on a direct basis in the United States and Canada and through third-party distributors in other international markets. The company supplies FDA 510(k) cleared water purification systems to the dialysis industry in North America. A significant portion of its sales in this segment are derived from sales of products and service to dialysis clinics and hospitals in North America.
Competition: On a product basis, the company’s competitors include Evoqua, IsoPure, Baxter and Steris.
Dental segment
This segment designs, manufactures, sells, supplies and distributes a selection of products used by the global dental profession, comprising a circle of protection. The company’s products include hand and powered dental instruments, infection control products, personal protective equipment (PPE) and water quality products for the dental suite. Its products include dental hand instruments for preventive and diagnostic procedures, as well as orthodontic, restorative, endodontic and surgical procedures; powered dental instrumentation and accessories, specifically for ultrasonic scaling and air polishing; instrument reprocessing and sterility assurance products, such as sterilization cassettes, cleaning solutions, biological sterilization indicators, chemical integrators and sterilization wraps and pouches; consumables, such as towels, bibs, tray liners and sponges; nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks; personal barrier products, such as face masks, shields, and hand protection products, such as hand sanitizers and germicidal wipes; cleaning solutions, high level disinfectants and surface disinfectants; waterline treatment products for maintaining safe dental unit waterlines; treatment accessories, such as saliva ejectors, evacuator tips and plastic cups; and preventatives such as prophy angles and prophy paste.
Significant brand names for the company’s dental products include EVEREDGE Scalers, IMS Cassettes, SWIVEL Ultrasonic Inserts, PERMASHARP Sutures, PROXIMATOR Instruments, ENZYMAX Cleaner, AXESS and CLEARVIEW Nasal Masks, SECURE FIT Masks, ISOFLUID Masks, ADVANTACLEAR, DICIDE and RAPICIDE Disinfectants, Vista Waterline Treatments and DentaPure Cartridges.
The company’s Crosstex brand is a supplier of primarily single-use products, including PPE, such as surgical masks, gowns, tray liners, barriers, sterilization wraps and pouches and chemistries, such as surface disinfectants and cleaning products. Its sterility assurance business includes biological indicators, chemical integrators and related products, both mail-in lab services and in-office biological monitoring (spore test) systems enabling hospitals, surgical centers, office-based practitioners and dental facilities to safely and monitor and verify their sterilization practices and protocols. Through Accutron, the company supplies nitrous oxide sedation systems and related consumables, such as sedation masks.
Sales, Marketing, and Distribution: The company’s dental products are sold worldwide to approximately 350 wholesale customers in approximately 100 countries. Its distribution partners primarily include major healthcare distributors, with some Group Purchasing Organizations and buying co-operatives that sell its products to dental practices, medical facilities, veterinary clinics, and government and educational institutions. The company sells dental products directly to educational institutions, government agencies and community health centers. Hu-Friedy maintains presence in dental schools. The majority of its dental products are sold under its brand names. The company also engages in supplying private label products for its various distribution partners and for other dental brand manufacturers.
Competition: On a product basis, the company’s competitors include Halyard Health, 3M, ASP, Steris, Danaher/Sybron, Dentsply/Sultan Healthcare, Amcor, Porter Instrument, Sterisil, ProEdge, J&J/Ethicon, LM Dental, Medicom, Young Dental, Braun/Aesculap and less expensive imported generic products from Asia and other lower cost manufacturing locations.
Dialysis segment
This segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers (a device serving as an artificial kidney), as well as dialysate concentrates and supplies utilized for renal dialysis. The company’s renal dialysis products include hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants.
The company’s renal dialysis treatment products include a line of acid and bicarbonate concentrates, referred to as dialysate concentrates, used by kidney dialysis centers to prepare dialysate, a chemical solution that draws waste products from the patient’s blood through a dialyzer membrane during the hemodialysis treatment. Dialysate concentrates are used in the dialysis process, whether single-use or reuse dialyzers are being utilized.
The company’s dialyzer reprocessing products are limited to use by centers that choose to clean, disinfect and reuse dialyzers for the same patient, known as ‘dialyzer reuse’, rather than discard the dialyzers after a single use. There has been a significant downward trend in dialyzer reuse since 2001, which has significantly decreased sales of the company’s dialysis products tied to reuse during that period. The company is exploring dialysis-related opportunities with the potential to mitigate the loss of such business.
Sales, Marketing and Distribution: The company’s products are sold in the United States and, to a lesser extent, internationally. The company’s customer base includes large and small dialysis chains, as well as independent dialysis clinics. The company sells products in the United States primarily through its own direct distribution network, and in majority of international markets either directly or under various third-party distribution agreements.
Competition: In this segment, the company’s most significant competition comes from manufacturers of single-use dialyzers, particularly Fresenius.
Intellectual Property
As of July 31, 2020, the company held 97 U.S. patents and 373 foreign patents, with 53 U.S. patents pending and 107 foreign patents pending. The majority of its U.S. and foreign patents for individual products are effective for twenty years from the initial filing date.
As of July 31, 2020, the company had 2,360 trademark registrations in the United States and in various foreign countries in which it conducts business, as well as 26 trademark applications pending worldwide.
Research and Development
The company’s research and development expenses (which include continuing engineering costs) were $32,372 in the year ended July 31, 2020.
Significant events
In December 2020, the company and Censis Technologies announced a long-term partnership to develop differentiated endoscope reprocessing software solution.
History
Cantel Medical Corp. was founded in 1963. The company was incorporated in 1963.
